Zidovudine treatment in HIV-infected pregnant women is associated with fetal cardiac remodelling
Por:
García-Otero L, López M, Gómez O, Goncé A, Bennasar M, Martínez JM, Valenzuela-Alcaraz B, Rodriguez-López M, Sitges M, Loncà M, Bijnens B, Crispi F and Gratacós E
Publicada:
1 jun 2016
Resumen:
To evaluate the cardiac structure and function of the fetuses of pregnant women with HIV infection on combined antiretroviral treatment (cART) and the HIV-related and nonrelated determinants of abnormal findings.
Filiaciones:
García-Otero L:
aBCNatal - Barcelona Center for Maternal-Fetal and Neonatal Medicine (Hospital Clínic and Hospital Sant Joan de Deu), Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Universitat de Barcelona, and Centre for Biomedical Research on Rare Diseases (CIBER-ER) bDepartment of Cardiology, Thorax Clinic Institute, Hospital Clínic, Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), University of Barcelona cInfectious Diseases Department, Hospital Clinic, Fundació Clíni
Open Access
|